
Pharma giant GSK has bought cancer specialist Sierra Oncology
(Picture: PA)Pharmaceutical giant GlaxoSmithKline (GSK) has bought California-based cancer treatment company Sierra Oncology for $1.9 billion (£1.5 billion).
Sierra is in the process of submitting its momelotinib drug for regulatory approval later in the year.